27-Jan-2026
Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus
Business Wire (Thu, 15-Jan 7:15 AM ET)
Business Wire (Thu, 15-Jan 7:00 AM ET)
IDEXX Announces CEO Succession
Business Wire (Tue, 13-Jan 8:30 AM ET)
IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results
Business Wire (Fri, 9-Jan 1:30 PM ET)
IDEXX Laboratories Delivers Double-Digit Revenue and EPS Growth, Boosts Outlook for 2025
Market Chameleon (Mon, 3-Nov 6:16 AM ET)
IDEXX Laboratories Lifts 2025 Outlook as Diagnostics Drive Double-Digit Growth
Market Chameleon (Mon, 3-Nov 2:37 AM ET)
IDEXX Laboratories Announces Third Quarter Results
Business Wire (Mon, 3-Nov 6:30 AM ET)
IDEXX Stock Rockets 26.5% After Earnings—Can History Offer Clues to What Happens Next?
Market Chameleon (Mon, 4-Aug 7:40 AM ET)
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Idexx Laboratories trades on the NASDAQ stock market under the symbol IDXX.
As of January 27, 2026, IDXX stock price declined to $694.75 with 287,127 million shares trading.
IDXX has a beta of 0.78, meaning it tends to be less sensitive to market movements. IDXX has a correlation of 0.15 to the broad based SPY ETF.
IDXX has a market cap of $56.30 billion. This is considered a Large Cap stock.
Last quarter Idexx Laboratories reported $1 billion in Revenue and $3.22 earnings per share. This beat revenue expectation by $34 million and exceeded earnings estimates by $.08.
In the last 3 years, IDXX traded as high as $769.98 and as low as $356.14.
The top ETF exchange traded funds that IDXX belongs to (by Net Assets): VTI, VOO, QQQ, VO, IVV.
IDXX has outperformed the market in the last year with a return of +59.6%, while the SPY ETF gained +15.6%. In the last 3 month period, IDXX beat the market returning +8.4%, while SPY returned +3.0%. However, in the most recent 2 weeks IDXX has underperformed the stock market by returning -4.1%, while SPY returned 0.0%.
IDXX support price is $685.63 and resistance is $710.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IDXX shares will trade within this expected range on the day.